Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Azithromycin ophthalmic - InSite Vision

Next Previous
X
Search
Drug Profile

Azithromycin ophthalmic - InSite Vision

Alternative Names: AzaSite; Azasite; AzaSite Xtra; Azimycin; azithromycin ophthalmic 1% - InSite Vision; azithromycin ophthalmic 2% - InSite Vision; ISV-401; ISV-405; SJP-0118

Latest Information Update: 04 Jan 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator InSite Vision
  • Developer Akorn; InSite Vision; Merck & Co; Senju Pharmaceutical; Tottori University Hospital
  • Class Anti-inflammatories; Antibacterials; Antivirals; Eye disorder therapies; Macrolides; Small molecules
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Conjunctivitis

Highest Development Phases

  • Marketed Blepharitis; Conjunctivitis; Dacryocystitis; Hordeolum; Infectious conjunctivitis
  • Discontinued Chalazion; Infectious keratitis

Most Recent Events

  • 04 Jan 2024 Discontinued - Phase-III for Blepharitis in Japan (Instillation) before January 2024
  • 04 Jan 2024 Discontinued - Phase-III for Chalazion in Japan (Instillation) before January 2024
  • 13 Jun 2018 No development reported - Phase-III for Blepharitis in Japan (Instillation)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top